These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 9649149)

  • 1. Combined analysis of differentiation inhibitory factor nm23-H1 and nm23-H2 as prognostic factors in acute myeloid leukaemia.
    Wakimoto N; Yokoyama A; Okabe-Kado J; Nagata N; Motoyoshi K; Honma Y
    Br J Cancer; 1998 Jun; 77(12):2298-303. PubMed ID: 9649149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation by multivariate analysis of the differentiation inhibitory factor nm23 as a prognostic factor in acute myelogenous leukemia and application to other hematologic malignancies.
    Yokoyama A; Okabe-Kado J; Wakimoto N; Kobayashi H; Sakashita A; Maseki N; Nakamaki T; Hino Ki; Tomoyasu S; Tsuruoka N; Motoyoshi K; Nagata N; Honma Y
    Blood; 1998 Mar; 91(6):1845-51. PubMed ID: 9490665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differentiation inhibitory factor Nm23 as a prognostic factor for acute myeloid leukemia.
    Okabe-Kado J; Kasukabe T; Honma Y
    Leuk Lymphoma; 1998 Dec; 32(1-2):19-28. PubMed ID: 10036998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differentiation inhibitory factor nm23 as a new prognostic factor in acute monocytic leukemia.
    Yokoyama A; Okabe-Kado J; Sakashita A; Maseki N; Kaneko Y; Hino K; Tomoyasu S; Tsuruoka N; Kasukabe T; Honma Y
    Blood; 1996 Nov; 88(9):3555-61. PubMed ID: 8896423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Expression of nm23 genes in acute myeloid leukemia and its clinical significance].
    Meng QX; Jiang R; Yang BQ; Zhang HY; Liu J; Pang LP; Wang J
    Zhonghua Xue Ye Xue Za Zhi; 2003 Jul; 24(7):369-71. PubMed ID: 12941193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum nm23-H1 protein as a prognostic factor in hematological malignancies.
    Okabe-Kado J
    Leuk Lymphoma; 2002 Apr; 43(4):859-67. PubMed ID: 12153176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma levels of the differentiation inhibitory factor nm23-H1 protein and their clinical implications in acute myelogenous leukemia.
    Niitsu N; Okabe-Kado J; Nakayama M; Wakimoto N; Sakashita A; Maseki N; Motoyoshi K; Umeda M; Honma Y
    Blood; 2000 Aug; 96(3):1080-6. PubMed ID: 10910925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated expression of differentiation inhibitory factor nm23 mRNA in monoblastic crisis of a patient with chronic myelogenous leukemia.
    Wakimoto N; Yokoyama A; Mukai Y; Kuwada N; Yamashita T; Matsumura T; Nakamura Y; Kanatani Y; Nagata N; Okabe-Kado J; Honma Y; Motoyoshi K
    Int J Hematol; 1998 Apr; 67(3):313-8. PubMed ID: 9650453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of metastasis-related nm23-H1 and nm23-H2 genes in ovarian carcinomas: correlation with clinicopathology, EGFR, c-erbB-2, and c-erbB-3 genes, and sex steroid receptor expression.
    Mandai M; Konishi I; Koshiyama M; Mori T; Arao S; Tashiro H; Okamura H; Nomura H; Hiai H; Fukumoto M
    Cancer Res; 1994 Apr; 54(7):1825-30. PubMed ID: 7907945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of nm23-H1 and nm23-H2 genes in colorectal carcinomas and loss of nm23-H1 expression in advanced tumour stages.
    Martinez JA; Prevot S; Nordlinger B; Nguyen TM; Lacarriere Y; Munier A; Lascu I; Vaillant JC; Capeau J; Lacombe ML
    Gut; 1995 Nov; 37(5):712-20. PubMed ID: 8549951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical significance of nm23-H1 proteins expressed on cell surface in non-Hodgkin's lymphoma.
    Niitsu N; Honma Y; Iijima K; Takagi T; Higashihara M; Sawada U; Okabe-Kado J
    Leukemia; 2003 Jan; 17(1):196-202. PubMed ID: 12529678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated plasma level of differentiation inhibitory factor nm23-H1 protein correlates with risk factors for myelodysplastic syndrome.
    Ito Y; Okabe-Kado J; Honma Y; Iwase O; Shimamoto T; Ohyashiki JH; Ohyashiki K
    Leukemia; 2002 Feb; 16(2):165-9. PubMed ID: 11840281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variability of nm23-H1/NDPK-A expression in human lymphomas and its relation to tumour aggressiveness.
    Aryee DN; Simonitsch I; Mosberger I; Kos K; Mann G; Schlögl E; Pötschger U; Gadner H; Radaszkiewicz T; Kovar H
    Br J Cancer; 1996 Dec; 74(11):1693-8. PubMed ID: 8956779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NM23-H1 and NM23-H2 messenger RNA abundance in human hepatocellular carcinoma.
    Iizuka N; Oka M; Noma T; Nakazawa A; Hirose K; Suzuki T
    Cancer Res; 1995 Feb; 55(3):652-7. PubMed ID: 7530600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of nm23 protein expression in renal cell carcinomas.
    Nakagawa Y; Tsumatani K; Kurumatani N; Cho M; Kitahori Y; Konishi N; Ozono S; Okajima E; Hirao Y; Hiasa Y
    Oncology; 1998; 55(4):370-6. PubMed ID: 9663430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. nm23-H1 expression in nasopharyngeal carcinoma: correlation with clinical outcome.
    Guo X; Min HQ; Zeng MS; Qian CN; Huang XM; Shao JY; Hou JH
    Int J Cancer; 1998 Dec; 79(6):596-600. PubMed ID: 9842967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of nm23/NDP kinase proteins on the cell surface.
    Urano T; Furukawa K; Shiku H
    Oncogene; 1993 May; 8(5):1371-6. PubMed ID: 8386830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of human nm23-H1 and nm23-H2 proteins in hepatocellular carcinoma.
    Yamaguchi A; Urano T; Goi T; Takeuchi K; Niimoto S; Nakagawara G; Furukawa K; Shiku H
    Cancer; 1994 May; 73(9):2280-4. PubMed ID: 8168032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of nm23-H1 and nm23-H2 proteins in prostate carcinoma.
    Konishi N; Nakaoka S; Tsuzuki T; Matsumoto K; Kitahori Y; Hiasa Y; Urano T; Shiku H
    Jpn J Cancer Res; 1993 Oct; 84(10):1050-4. PubMed ID: 7693635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High nm23-H1/NDPK-A expression in Ewing tumors: paradoxical immunohistochemical reactivity and lack of prognostic significance.
    Aryee DN; Ströbel T; Kos K; Salzer-Kuntschik M; Zoubek A; Veron M; Ambros IM; Traincart F; Gadner H; Kovar H
    Int J Cancer; 1995 Apr; 64(2):104-11. PubMed ID: 7542225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.